Diaphragmatic Dysfunction After Ultrasound-guided Supraclavicular Block With Single or Double Injection Technique

Anesthesia Clinical Trial

Official title:

Diaphragmatic Dysfunction After Ultrasound-guided Supraclavicular Brachial Plexus Block With Single or Double Injection Technique

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT02795598
• Other study ID #: 1021191
• Status: Withdrawn
• Phase: N/A
• Start date: August 2016
• Est. completion date: June 1, 2018

Study information

• Verified date: July 2016
• Source: Nova Scotia Health Authority
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The investigators plan to determine the incidence of hemi-diaphragmatic paresis (HDP) with two commonly used techniques of supraclavicular nerve block, the single and double injection techniques.

It is our hypothesis that a double injection peripheral nerve block technique will increase the risk of HDP when compared to a single injection technique.

Description:

The investigators will perform a prospective, blinded, randomized controlled trial to assess the two methods of supraclavicular block (single and double injection), and the resultant incidence of temporary diaphragm dysfunction, or hemi-diaphragmatic paresis (HDP) will be measured with ultrasound. Patients having forearm or hand surgery will be asked by the attending anesthesiologist if they will agree to be approached by someone from the research team for consent and possible inclusion in the study. This will be done in the anesthesia preoperative assessment clinic, or in the pre-op area on the day of surgery (if a patient was not seen in clinic).

Once consented, all patients in the study will have baseline measurements of their sensation and movement of the arm for surgery, as well as an ultrasound examination of the movement of the diaphragm.

Patients will then be randomized to either the single or double injection supraclavicular nerve block. The blocks will be performed by attending anesthesiologists with experience in regional anesthesia, or by residents and fellows under the direct supervision of such anesthesiologists.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: June 1, 2018
• Est. primary completion date: June 1, 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients presenting for unilateral upper extremity surgery below the level of the elbow (the forearm or hand) who are having a regional block for anesthesia

• Patient must be over 18 years old

• Weight greater than 50kg

• English speaking

• Be available to be contacted by phone on post-operative day 1

• ASA physical status 1-3

• BMI under 35 kg/m2

Exclusion Criteria:

• Inability to consent to study participation

• Pre-existing neuromuscular disease or severe neurological dysfunction

• Severe coagulopathy

• Severe obstructive or restrictive lung disease

• Pregnancy

• Prior surgery in the supraclavicular region

• Allergy to medications used in the study

• Known diaphragmatic dysfunction of either diaphragm

• Inability to visualize the diaphragm with ultrasound on the side of the surgical procedure

• Highly opioid-tolerant patient (>40mg of morphine PO or equivalent per day for >1month)

• Patient requests a general anesthesia technique

• Attending anesthesiologist preference for alternate anesthetic technique

• Surgeon or attending anesthesiologist request for a different anesthesia technique

• Current involvement in another study

Related Conditions & MeSH terms

• Anesthesia

Intervention

Procedure:
• Single injection supraclavicular nerve block
The ultrasound probe will be applied in a sterile fashion in the supraclavicular fossa to obtain a short-axis view of the subclavian artery. A 22G, 50mm Echogenic Stimuplex needle will be advanced in-plane with respect to the image, and the needle tip will be advanced to the junction of the first rib and subclavian artery. Ultrasound cineloops will be kept of all nerve block procedures. 30 milliliters of mepivacaine 1.5% will be injected incrementally in 5ml boluses at this location looking for spread of local anesthetic under and medial to the subclavian artery. The needle may be slightly repositioned to improve the distribution of the injectate at the discretion of the attending anesthesiologist.
• Double injection supraclavicular nerve block
The ultrasound probe will be applied in a sterile fashion in the supraclavicular fossa to obtain a short-axis view of the subclavian artery. A 22G, 50mm Echogenic Stimuplex needle will be advanced in-plane with respect to the image, and the needle tip will be advanced to the junction of the first rib and subclavian artery. Ultrasound cineloops will be kept of all nerve block procedures. 15 milliliters of mepivacaine 1.5% will be injected incrementally at the same, above-mentioned location. The needle will then be redirected to the superolateral aspect of the brachial plexus, and an additional 15ml will be injected here. Again, the needle may slightly repositioned at the discretion of the attending anesthesiologist in order to obtain adequate spread.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Nova Scotia Health Authority

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Incidence of Hemidiaphragmatic paresis (HDP) by diaphragmatic thickening	Ultrasound measurement of diaphragmatic thickening	Relative change in ultrasound assessment of diaphragmatic thickening (Baseline vs 30 min after supraclavicular block)
Secondary	Onset time of sensory block	Sensation of the terminal peripheral nerves of the upper extremity will be assessed by a single observer blinded to the technique for the musculocutaneous, median, radial, ulnar and the medial antebrachial cutaneous nerves. Sensory assessments will be done using a blunt needle and the response will be assessed on a 3-point scale using the contralateral limb as a control: 0 = normal sensation, 1 = hypoesthesia, and 2 = anesthesia. A composite score will be created for each time point.	Baseline, 5, 10, 15, 20, 25, and 30 minutes after block
Secondary	Onset time of motor block	Motor blockade of the musculocutaneous, radial, median, and ulnar nerves will be evaluated by elbow flexion, thumb abduction, thumb opposition, and thumb adduction, respectively. Motor blockade will be graded on a 3-point scale: 0 = normal strength, 1 = weakness relative to the contralateral side, and 2 = complete paralysis. A composite score will be created for each time point.	Baseline, 5, 10, 15, 20, 25, and 30 minutes after block
Secondary	Bedside spirometry - forced expiratory volume at one second (FEV1)	Relative changes in forced expiratory volume at one second (FEV1) will be compared	Relative change in FEV1 (Baseline vs 30 min after supraclavicular block)
Secondary	Bedside spirometry - forced vital capacity (FVC)	Relative changes in forced vital capacity (FVC) will be compared	Relative change in FVC (Baseline vs 30 min after supraclavicular block)
Secondary	Dyspnea	Patient will be asked if they are having shortness of breath.	30 minutes after the supraclavicular block
Secondary	Procedure performance time	Measurement of time taken to perform both types of block	From the time that the block needle enters skin until it is removed
Secondary	Incidence of complications	The incidence of complications, including puncturing a vessel, or post-operative sensory or movement problems	From block performance until 24 hours after block is completed (24 hour follow-up call)
Secondary	Clinical Efficacy	Nerve blocks will be considered clinically efficacious if surgery is able to proceed without the need for additional local anesthesia at the site or need for general anesthesia. Any use of supplemental local or general anesthesia will be considered a block failure.	At the time of surgery start
Secondary	Incidence of Hemidiaphragmatic paresis (HDP) by diaphragmatic excursion	Ultrasound measurement of HDP	Relative change in ultrasound assessment of diaphragmatic excursion (Baseline vs 30 min after supraclavicular block)